secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001641172-25-008389
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics appoints Janet Huffman as permanent CEO; shareholders authorize reverse stock split up to 1:50
--------------------------------------------------------------------------------

- Janet Huffman, previously CFO and Interim CEO, appointed permanent CEO effective May 2, 2025 under one-year agreement.
- Base salary $325,000, bonus target up to 50% of base, severance includes 6 months salary and change-in-control provisions.
- Shareholders authorized a reverse stock split of common stock between 1:5 and 1:50 ratio, Board to determine exact ratio.
- Authorized increase in authorized shares to 350M contingent on reverse split; 2021 Equity Incentive Plan shares increased to 3,166,667.
- All five directors re-elected: Pope, Telling, Koski, Dunton, Gandolfo. Auditor Cherry Bekaert ratified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000164117225008389/0001641172-25-008389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000164117225008389/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer